Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 401–500 of 911
Shimamoto, A., Yokote, K., & Tahara, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00010 · Cited by 40
Cerezo, A., Stark, H., Moshir, S., & Boukamp, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12304.x · Cited by 41
Disruption of Oncogene/Tumor Suppressor Networks During Human Carcinogenesis
Münger, K. (2002) · Cancer Investigation · doi:10.1081/cnv-120000369 · Cited by 46
Hong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Ali, J. H., & Walter, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03041-2 · Cited by 39
Giunco, S., Celeghin, A., Gianesin, K., Dolcetti, R., Indraccolo, S., & Rossi, A. D. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.145 · Cited by 40
Tan, S. C., Gomes, R. S. M., Yeoh, K. K., Perbellini, F., Malandraki-Miller, S., Ambrose, L. J. A., Heather, L. C., Faggian, G. G., Schofield, C. J., Davies, K. E., et al. (2016) · Cell Transplantation · doi:10.3727/096368915x687697 · Cited by 38
hTERT: Another brick in the wall of cancer cells
Lamy, E., Goetz, V., Erlacher, M., Herz, C., & Mersch‐Sundermann, V. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.12.005 · Cited by 38
The correlation of TERT expression with c-myc expression in cervical cancer
Sagawa, Y., Nishi, H., Isaka, K., Fujito, A., & Takayama, M. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00501-8 · Cited by 37
Nylander, K., Bourdon, J.-C., Bray, S. E., Gibbs, N. K., Kay, R., Hart, I., & Hall, P. A. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1<39::aid-path492>3.0.co;2-v · Cited by 98
Telomerase as a new target for the treatment of hormone-refractory prostate cancer
Biroccio, A., & Leonetti, C. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00764 · Cited by 40
Telomere protein complexes and interactions with telomerase in telomere maintenance
Pinto, A. R., Li, H., Nicholls, C., & Liu, J. (2010) · Frontiers in bioscience · doi:10.2741/3683 · Cited by 40
Diverse regulatory manners of human telomerase reverse transcriptase
Jie, M., Chang, X., Zeng, S., Liu, C., Liao, G., Wu, Y., Liu, C., Hu, C.-J., Yang, S., & Li, X. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0372-0 · Cited by 38
Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
Kumar, N., & Sethi, G. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216459 · Cited by 41
Liu, F., Li, H., Chang, H., Wang, J., & Lu, J. (2015) · Tumori Journal · doi:10.5301/tj.5000241 · Cited by 36
Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation
Krupp, G., Klapper, W., & Parwaresch, R. M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000708 · Cited by 41
Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities
Trabzonlu, L., Kulaç, İ., Zheng, Q., Hicks, J. L., Haffner, M. C., Nelson, W. G., Sfanos, K. S., Ertunç, O., Lotan, T. L., Heaphy, C. M., et al. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030403 · Cited by 40
Telomerase, immortality and cancer
Krupp, G., Bonatz, G., & Parwaresch, R. M. (2000) · Biotechnology annual review · doi:10.1016/s1387-2656(00)06020-8 · Cited by 39
Wang, Y., Kowalski, J., Tsai, H., Marik, R., Prasad, N. B., Somervell, H., Lo, P., Sangenario, L. E., Dyrskjøt, L., Orntoft, T. F., et al. (2008) · Thyroid · doi:10.1089/thy.2008.0101 · Cited by 35
Huang, S., Wang, C., Yang, R.-C., Chu, C.-J., Wu, H., & Pang, J. S. (2009) · Complementary Medicine Research · doi:10.1159/000194154 · Cited by 41
Shieh, G.-S., Shiau, A., Yo, Y.-T., Lin, P., Chang, C.-C., Tzai, T., & Wu, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1138 · Cited by 35
Auvinen, M. I., Järvinen, K., Hotti, A., Okkeri, J., Laitinen, J., Jänne, O. A., Coffino, P., Bergman, M., Andersson, L. C., Alitalo, K. K., et al. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00305-9 · Cited by 35
c-Myc-mediated Regulation of Telomerase Activity Is Disabled in Immortalized Cells
Drissi, R., Zindy, F., Roussel, M. F., & Cleveland, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101899200 · Cited by 39
Growth-Related Signaling Regulates Activation of Telomerase in Regenerating Hepatocytes
Inui, T., Shinomiya, N., Fukasawa, M., Kobayashi, M. S., Kuranaga, N., Ohkura, S., & Seki, S. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5446 · Cited by 36
Zaffaroni, N., Porta, C. D., Villa, R., Botti, C., Buglioni, S., Mottolese, M., & Daidone, M. G. (2002) · The Journal of Pathology · doi:10.1002/path.1178 · Cited by 40
Stem cell therapy for Parkinson?s disease: where do we stand?
Roybon, L., Christophersen, N. S., Brundin, P., & Li, J. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0946-y · Cited by 38
Epigenetic aspects of cellular senescence
Young, J. I., & Smith, J. R. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(99)00076-5 · Cited by 39
Safa, M., Tavasoli, B., Shabestari, R. M., Kiani, F., Kashiri, M., Ebrahimi, S., & Kazemi, A. (2015) · Tumor Biology · doi:10.1007/s13277-014-3035-1 · Cited by 39
Verykokakis, M., Papadaki, C., Vorgia, E., Gallic, L. L., & Mavrothalassitis, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704428200 · Cited by 46
Machado-Pinilla, R., Sánchez‐Pérez, I., Murguía, J. R., Sastre, L., & Perona, R. (2007) · Blood · doi:10.1182/blood-2007-04-083261 · Cited by 34
Molecular abnormalities in Ewing’s sarcoma
Burchill, S. A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1675 · Cited by 34
Glienke, W., Chow, K. U., Bauer, N. G., & Bergmann, L. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600625398 · Cited by 34
Yago, M., Ohki, R., Hatakeyama, S., Fujita, T., & Ishikawa, F. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02757-6 · Cited by 38
Genetic Analysis of Myc and Telomerase Interactions In Vivo
Flores, I., Evan, G., & Blasco, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00543-06 · Cited by 33
Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma
Zender, L., & Kubicka, S. (2008) · Onkologie · doi:10.1159/000151586 · Cited by 36
WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix
Delmas, A. L., Riggs, B. M., Pardo, C. E., Dyer, L. M., Darst, R. P., Izumchenko, E. G., Monroe, M., Hakam, A., Kladde, M. P., Siegel, E. M., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr193 · Cited by 33
DKC1 is a direct and conserved transcriptional target of c-MYC
Alawi, F., & Lee, M. N. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.071 · Cited by 33
InTERTesting association between telomerase, mTOR and phytochemicals
Sundin, T., & Hentosh, P. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.1 · Cited by 35
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor
Wu, P., Li, M., Wang, H., Zhou, J., Xu, G., Wang, S., Xi, L., Chen, G., Wang, B., Zhu, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.039 · Cited by 34
Kuschak, T. I., Taylor, C., McMillan‐Ward, E., Israels, S. J., Henderson, D. W., Mushinski, J. F., Wright, J. A., & Mai, S. (1999) · Gene · doi:10.1016/s0378-1119(99)00341-8 · Cited by 33
Nakabayashi, K., Ogino, H., Michishita, E., Satoh, N., & Ayusawa, D. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4619 · Cited by 37
Mascaro-Cordeiro, B., Oliveira, I. D., Alves, M. T. D. S., Saba‐Silva, N., Capellano, A. M., Cavalheiro, S., Dastoli, P. A., & de Toledo, S. R. C. (2014) · Child s Nervous System · doi:10.1007/s00381-014-2403-x · Cited by 33
Long, W. S., Zheng, B., Huang, X., She, M., Liu, A.-L., Zhang, K., Wong, W., & Lu, Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01656 · Cited by 32
Kotiyal, S., & Evason, K. J. (2021) · Cancers · doi:10.3390/cancers13164202 · Cited by 33
RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer
Flavin, P., Redmond, A. M., McBryan, J., Cocchiglia, S., Tibbitts, P., Fahy-Browne, P., Kay, E. W., Treumann, A., Perrem, K., McIlroy, M., et al. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.005 · Cited by 35
Oligonucleotide microarray analysis of ameloblastoma compared with dentigerous cyst
Lim, J.-J., Ahn, H., Min, S., Hong, S., Lee, J., & Hong, S. (2006) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2006.00393.x · Cited by 32
Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT
Moon, D., Kim, M.-O., Choi, Y. H., Lee, H. G., Kim, N. D., & Kim, G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.08.029 · Cited by 32
Differential repression of human and mouse TERT genes during cell differentiation
Wang, S., Zhao, Y., Hu, C., & Zhu, J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp125 · Cited by 36
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
Fiaschetti, G., Castelletti, D., Zoller, S., Schramm, A. R., Schroeder, C., Nagaishi, M., Stearns, D. S., Mittelbronn, M. G. A., Eggert, A., Westermann, F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.10 · Cited by 32
2,3,7,8-tetrachlorodibenzo-p-dioxin and the viral infection
Fiorito, F., Santamaria, R., Irace, C., Martino, L. D., & Iovane, G. (2016) · Environmental Research · doi:10.1016/j.envres.2016.11.004 · Cited by 33
Renaud, S., Bosman, F. T., & Benhattar, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02775-4 · Cited by 34
αCP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone
Emerald, B. S., Chen, Y., Zhu, T., Zhu, Z., Lee, K., Gluckman, P. D., & Lobie, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600224200 · Cited by 33
The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes
Sheng, W.-Y., Chien, Y.-L., & Wang, T. V. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00230-8 · Cited by 36
Finnon, P., Silver, A. R., & Bouffler, S. D. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.573 · Cited by 33
Hines, W. C., Fajardo, A. M., Joste, N. E., Bisoffi, M., & Griffith, J. K. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0031 · Cited by 38
Dovey, Z. S., Nair, S. S., Chakravarty, D., & Tewari, A. K. (2021) · Cancer Reports · doi:10.1002/cnr2.1340 · Cited by 33
Wu, S.-H., Yu, J.-H., Liao, Y., Liu, K.-H., Chiang, E., Chang, M.-C., & Wang, J. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00431-x · Cited by 34
Mormone, E., Iorio, E. L., Abate, L., & Rodolfo, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1073689 · Cited by 31
Correlation of dyskerin expression with active proliferation independent of telomerase
Alawi, F., Lin, P., Ziober, B. L., & Patel, R. G. (2010) · Head & Neck · doi:10.1002/hed.21579 · Cited by 34
de Wilde, J., Wilting, S. M., Meijer, C. J. L. M., van de Wiel, M. A., Ylstra, B., Snijders, P. J. F., & Steenbergen, R. D. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23210 · Cited by 35
Oh, B.-K., Kim, Y., Park, Y. N., Choi, J., Kim, K. S., & Park, C. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00532.x · Cited by 31
Miller, H. D., Clark, B. W., Hinton, D. E., Whitehead, A., Martin, S., Kwok, K. W. H., & Kullman, S. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052479 · Cited by 31
Butylidenephthalide Suppresses Human Telomerase Reverse Transcriptase (TERT) in Human Glioblastomas
Lin, P., Lin, S., Chen, Y.-L., Chang, J., Ho, L.-I., Liu, P.-Y., Chang, L.-F., Harn, Y., Chen, S., Sun, L., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1644-0 · Cited by 32
Stimulation of c-Rel transcriptional activity by PKA catalytic subunit ?
Yu, S.-H., Chiang, W., Shih, H.-M., & Wu, K.-J. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0559-7 · Cited by 33
Self-citationGenetic changes associated with telomerase activity in breast cancer
Loveday, R. L., Greenman, J., Drew, P. J., Monson, J. R. T., & Kerin, M. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<516::aid-ijc12>3.0.co;2-y · Cited by 33
Dissecting the non-canonical functions of telomerase
Parkinson, E. K., Fitchett, C., & Cereser, B. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167813 · Cited by 29
A shRNA Functional Screen Reveals Nme6 and Nme7 Are Crucial for Embryonic Stem Cell Renewal
Wang, C.-H., Ma, N. J.-L., Lin, Y.-T., Wu, C.-C., Hsiao, M., Lu, F. L., Yu, C.-C., Chen, S.-Y., & Lu, J. (2012) · Stem Cells · doi:10.1002/stem.1203 · Cited by 32
Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1
Cerni, C., Skrzypek, B., Popov, N., Sasgary, S., Schmidt, G., Larsson, L., Lüscher, B., & Arsenian‐Henriksson, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205107 · Cited by 30
Murakami, J., Asaumi, J., Kawai, N., Tsujigiwa, H., Yanagi, Y., Nagatsuka, H., Inoue, T., Kokeguchi, S., Kawasaki, S., Kuroda, M., et al. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0976-x · Cited by 30
Leben am Ende der Chromosomen: Telomere und Telomerase
Cech, T. R. (2000) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(20000103)112:1<157::aid-ange157>3.0.co;2-r · Cited by 30
Regulation of Telomerase by Human Papillomaviruses
Galloway, D. A., Gewin, L. C., Myers, H. E., LUO, W., Grandori, C., Katzenellenbogen, R. A., & McDougall, J. K. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.041 · Cited by 37
Self-citationNY-ESO-1 immunotherapy for multiple myeloma
Szmania, S. M., Tricot, G. J. K., & van Rhee, F. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600742292 · Cited by 31
Teralı, K., & Yılmazer, A. (2015) · Biochimie · doi:10.1016/j.biochi.2015.12.001 · Cited by 31
Telomerase and Telomeres Biology in Thyroid Cancer
Donati, B., & Ciarrocchi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122887 · Cited by 30
Tahtouh, R., Azzi, A., Alaaeddine, N., Chamat, S., Bouharoun‐Tayoun, H., Wardi, L., RAAD, I. I., Sarkis, R., Antoun, N. A., & Hilal, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119512 · Cited by 30
Zhou, C., & Liu, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00318-8 · Cited by 32
Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells
Yu, Z., Li, T., Wang, C., Deng, S., Zhang, B., Huo, X., Zhang, B., Wang, X., Zhong, Y., & Ma, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7398 · Cited by 30
Gocha, A. R. S., Harris, J. M., & Groden, J. L. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.11.006 · Cited by 33
Calcium-Mediated Telomerase Activity in Ovarian Epithelial Cells
Matte, M. Y. A.-D., Moses-Soto, H., & Kruk, P. A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2002.2762 · Cited by 28
Requirement of E7 oncoprotein for viability of HeLa cells
Nishimura, A., Nakahara, T., Ueno, T., Sasaki, K., Yoshida, S., Kyo, S., Howley, P. M., & Sakai, H. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.015 · Cited by 33
Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells
Dolci, S., Levati, L., Pellegrini, M., Faraoni, I., Graziani, G., Carlo, A. D., & Geremia, R. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1643 · Cited by 32
Buttitta, F., Pellegrini, C., Marchetti, A., Gadducci, A., Cosio, S., Felicioni, L., Barassi, F., Salvatore, S., Martella, C., Coggi, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.065 · Cited by 32
Mechanisms for telomerase gene control in aging cells and tumorigenesis
Tollefsbol, T. O., & Andrews, L. G. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1241 · Cited by 30
Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines
Hu, K., Ghandi, M., & Huang, F. W. (2021) · eLife · doi:10.7554/elife.66198 · Cited by 27
Breaking Tolerance in a Mouse Model of Multiple Myeloma by Chemoimmunotherapy
Sharabi, A., & Haran‐Ghera, N. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07001-6 · Cited by 28
Kumar, M., Witt, B., Knippschild, U., Koch, S., Meena, J. K., Heinlein, C., Weise, J. M., Krepulat, F., Kuchenbauer, F. C., Iben, S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27880 · Cited by 29
The Myc/macrophage tango: Oncogene-induced senescence, Myc style
Lee, S., Schmitt, C. A., & Reimann, M. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.002 · Cited by 31
Eitsuka, T., Tatewaki, N., Nishida, H., Nakagawa, K., & Miyazawa, T. (2016) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.62.281 · Cited by 27
Functional dissection of breast cancer risk-associated TERT promoter variants
Helbig, S., Wockner, L. F., Bouendeu, A., Hille‐Betz, U., McCue, K., French, J. D., Edwards, S. L., Pickett, H. A., Reddel, R. R., Chenevix‐Trench, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18226 · Cited by 30
Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies
Houshmand, M., Yazdi, N., Kazemi, A., Atashi, A., Hamidieh, A. A., Najemdini, A. A., Pour, M. M., & Zarif, M. N. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.03.001 · Cited by 27
Wang, S., Yan, W., He, M. Y., Wei, D., Long, Z.-J., & Tao, Y.-M. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00062-w · Cited by 28
Telomerase regulation in hematological cancers: A matter of stemness?
Deville, L., Hillion, J., & Ségal-Bendirdjian, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.016 · Cited by 29
Swanberg, S. E., Payne, W. S., Hunt, H. D., Dodgson, J. B., & Delany, M. E. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20149 · Cited by 29
Implications of Mapping the Human Telomerase Gene (hTERT) as the Most Distal Gene on Chromosome 5p
Shay, J. W., & Wright, W. E. (2000) · Neoplasia · doi:10.1038/sj.neo.7900093 · Cited by 35
Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones
Biroccio, A., Amodei, S., Benassi, B., Scarsella, M., Cianciulli, A. M., Mottolese, M., Bufalo, D. D., Leonetti, C., & Zupi, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205415 · Cited by 27
Chaves-Dias, C., Hundley, T., Gilfillan, A., Kirshenbaum, A., Cunha-Melo, J., Metcalfe, D., & Beaven, M. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.11.6647 · Cited by 30
Ikegaki, N., & Shimada, H. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00312 · Cited by 27
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis
von Stedingk, K., Köster, J., Piqueras, M., Noguera, R., Navarro, S., Påhlman, S., Versteeg, R., Øra, I., Gisselsson, D., Lindgren, D., et al. (2013) · Translational Oncology · doi:10.1593/tlo.13112 · Cited by 27
Structure and biological properties of five Pt(II) complexes as potential anticancer agents
Deng, J., Wang, J., Khan, M., Yu, P., Yang, F., & Liang, H. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.04.017 · Cited by 26
Jeda, A. S., Badrzadeh, F., Esghaei, M., & Abdoli, A. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100323 · Cited by 27
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.